Effects of CB1 cannabinoid receptor modulating compounds on the hyperkinesia induced by high-dose levodopa in the reserpine-treated rat model of Parkinson's disease. [electronic resource]
Producer: 20030604Description: 138-49 p. digitalISSN:- 0885-3185
- Adrenergic Uptake Inhibitors -- therapeutic use
- Animals
- Antiparkinson Agents -- administration & dosage
- Behavior, Animal -- drug effects
- Cannabinoid Receptor Modulators
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Fatty Acids, Unsaturated -- pharmacology
- Hyperkinesis -- chemically induced
- Levodopa -- administration & dosage
- Male
- Parkinson Disease -- drug therapy
- Rats
- Rats, Sprague-Dawley
- Receptors, Cannabinoid
- Receptors, Drug -- drug effects
- Reserpine -- therapeutic use
- Time Factors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.